Should We Test for CYP2C9 Before Initiating Anticoagulant Therapy in Patients with Atrial Fibrillation?
AUTOR(ES)
Eckman, Mark H.
FONTE
Springer-Verlag
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2669861Documentos Relacionados
- Testing for CYP2C9 Before Initiating Anticoagulant Therapy
- Testing for CYP2C9 Before Anticoagulant Therapy
- When should I stop anticoagulation for atrial fibrillation?
- Effect of iguratimod on diclofenac metabolism by CYP2C9 in rats and human recombinant CYP2C9 yeast cells
- Anticoagulation therapy for patients with atrial fibrillation